Tested >99.9% Anti-Coronavirus Activity – Reduce Risks of COVID-19 Infections and Transmissions with Optipura
“We now know how the efficacy in viral reduction of Optipura corresponds to the success of current Optipura hygiene applications. This, together with ease of implementation and professionalism supports the wider adoption of Optipura in spaces as a promising means in helping prevent serious COVID-19 infections and dreaded post COVID-19 effects.”
At the start of 2020 we highlighted in an article that COVID-19 was in fact not only transmitted via environments through contact with surfaces but also significantly through the air. This was soon recognized to be true by many including the World Health Organization .
Then we reasoned given real-world effectiveness in cases of reducing the transmission of virus infections in care centres, that Optipura’s plasma technology would benefit in applications against a wide range of viruses, including coronaviruses that infect humans. And according to independent lab tests we were right.
PROVEN ANTI-CORONAVIRUS ACTIVITY
Recent independent laboratory tests prove Optipura effective in deactivating human coronavirus. Here the efficacy of Optipura’s plasma to deactivate human coronavirus was determined to be more than 99.9%.
The test considered both the standard operation of Optipura and aspects of how coronavirus could be deposited on surfaces after being shed in an enclosed space.
What was found was not only did Optipura deactivate the coronavirus some distance away, but was also able to do so in a way unique to the sanitisation method, effectively proving both air and surface anti-viral activity.
The results therefore demonstrate the ability of Optipura’s technology to deactivate coronaviruses in applied spaces, and significantly so under conditions resembling those in the real-world.
Coronavirus deactivation determined by infecting healthy cells with viruses that were some distance away from an operating Optipura unit in a room.
Fig. 1. Optipura use in hygiene-dependent spaces such as kitchens help prevent spread of pathogenic bacteria, and pathogenic viruses.
A GREAT SOLUTION THEN AND NOW AGAINST COVID-19
Optipura commercial air purifiers have long been used in areas where a better level of hygiene is required in various scopes (Fig. 1), and with good outcomes.
Its utilisation of germicidal UV, accelerated photodegradation and plasma allows it to not only deactivate and kill germs such as bacteria and viruses that pass through the machine but also to sanitise the air and surfaces outside of the machine, beyond what other purifiers are capable of.
The confirmation of Optipura’s ability to deactivate the coronavirus as determined by the laboratory therefore did not come as a surprise to many existing hygiene-centric users. Instead it placed additional focus on the use of Optipura against the coronavirus and COVID-19.
With the coronavirus being better understood now, COVID-19 is proving to be more than a simple disease. While some people who were infected suffer a variety of long-term issues (see Fig. 2) described as post-COVID condition or “long COVID”  , many of those who make a full recovery only do so to get re-infected regardless their vaccination status [3, 4].
Given such and that many people may spend up to 90% of their time indoors , it thus becomes apparent that the avoidance of infections indoors by lowering exposure to the coronavirus becomes significant in minimizing, if not preventing severe COVID-19. This is precisely what Optipura does by significantly lowering coronavirus counts where people gather, and can do so safely and comfortably too.
OPTIPURA REDUCES YOUR RISK OF VIRAL INFECTIONS
We now know how the efficacy in viral reduction of Optipura corresponds to the success of current Optipura hygiene applications. This, together with ease of implementation and professionalism supports the wider adoption of Optipura in spaces as a promising means in helping prevent serious COVID-19 infections and dreaded post COVID-19 effects.
Optipura solutions are established, convenient to use, versatile and are known to work against some of the toughest challenges in deodorisation, sanitisation and purification, and thereby make for safer and more comfortable environments.
With our background and experience in professional hygiene enhancement and infection control in various health and care-related industries, your risks of having COVID-19 infections take place or spread in your working or living space are kept to the very minimal with Optipura.
Fig. 2. Some of about 200 post-COVID symptoms reported in patients.
Contact us to enquire on the full benefits of an Optipura anti-viral solution for areas in your workplace and to lower your risks of serious and long term COVID-19 infections.
- WHO Newsroom Q&A – Coronavirus disease (COVID-19): How is it transmitted.
- Diaz, J. (2021). World Health Organisation. Science in 5 – Episode 47 – Post COVID-19 condition
- Malhotra, S., et al (2021) – COVID-19 infection, and reinfection, and vaccine effectiveness against symptomatic infection among health care workers in the setting of omicron variant transmission in New Delhi, India. The Lancet – Regional Health, Southeast Asia.
- Rahman, S., et al (2022) – COVID-19 reinfections among naturally infected and vaccinated individuals. Nature. Scientific Reports 12, Article no. 1438 (2022).
- EPA – Report on the Environment – Indoor Air Quality. What are the trends in indoor air quality and their effects on human health? (2021)